OMNIAB, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
OMNIAB, INC. (OABI) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $1.17 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-06
- OMNIAB, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $588.00K, a 5.57% increase year-over-year.
- OMNIAB, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2026-03-31 was $580.00K, a 5.65% increase year-over-year.
- OMNIAB, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $557.00K.
- OMNIAB, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $549.00K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month |
|---|---|---|
| 2026-06-30 | $588.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.17M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $580.00K 10-Q · filed 2026-05-07 | |
| 2025-06-30 | $557.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.11M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $549.00K 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |